BioLife Solutions, Inc. (BLFS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 48 | 119 | 76 | 68 | 82 | 96 | 103 | 115 |
| Operating profit | $m | -1 | 7 | ||||||
| Net profit | $m | 2 | -9 | -140 | -66 | -20 | -12 | 50 | 29 |
| EPS reported | $ | -0.25 | 1.02 | ||||||
| Operating cashflow per share | $ | 0.42 | 0.35 | ||||||
| Capex per share | $ | 0.41 | 0.36 | ||||||
| FCF per share | $ | 0.01 | -0.02 | ||||||
| Free cash flow | $m | 0 | -1 | ||||||
| Net debt | $m | -84 | -82 | ||||||
| Book value equity | $m | 372 | 420 | ||||||
| Book value per share | $ | 7.64 | 8.52 | ||||||
| Number of shares | m | 48.65 | 49.29 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 37.60 | ||||||
| P/B LTM | x | 3.10 | 2.75 | ||||||
| P/S LTM | x | 12.00 | 11.23 | ||||||
| P/FCF LTM | x | 2,775.69 | -1,277.31 | ||||||
| EV/EBITDA LTM | x | 316.01 | 116.49 | ||||||
| EV/Sales LTM | x | 11.84 | 16.67 | ||||||
| Earnings Yield LTM | % | -1.05% | +2.66% | ||||||
| FCF Yield | % | +0.04% | -0.08% | ||||||
| Quality | |||||||||
| ROE | % | -3.26% | +13.29% | ||||||
| ROIC | % | -0.28% | +1.71% | ||||||
| Operating margin | % | -1.12% | +7.25% | ||||||
| Gross margin | % | +64.56% | +64.48% | ||||||
| FCF/Sales | % | +0.43% | -0.88% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +16.97% | +25.00% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -92.01% | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.02 | -0.06 | ||||||
| Net Debt/EBITDA | x | -4.20 | -0.84 | ||||||
| EBIT/Net interest | x | -0.40 | 11.29 | ||||||
| Net debt/market cap | % | +0.43% | 0.00% | ||||||
| Net debt/Equity | x | -0.23 | -0.20 | ||||||
| Gross debt/equity | x | 0.05 | 0.04 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free